Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta

Journal of Bone and Mineral Research

Volumn 21, Issue 3, 2006, Pages 374-379

  Land, Christof ^a   Rauch, Frank ^a,b   Glorieux, Francis H ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Children; Metaphyseal inwaisting; Osteogenesis imperfecta; Pamidronate

Indexed keywords

PAMIDRONIC ACID;

ADOLESCENT; ARTICLE; BONE DEVELOPMENT; BONE MALFORMATION; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR; GROWTH PLATE; HUMAN; HUMAN TISSUE; LONG BONE; MALE; METAPHYSIS; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; PERIOSTEUM; TRABECULAR BONE; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; BONE DEVELOPMENT; BONE REMODELING; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIPHOSPHONATES; FEMALE; FEMUR; HUMANS; INJECTIONS, INTRAVENOUS; MALE; OSTEOGENESIS IMPERFECTA;

EID: 33644540766     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.051207     Document Type: Article

References (16)

1. Rauch F, Glorieux FH 2004 Osteogenesis imperfecta. Lancet 363:1377-1385.
2. Rauch F 2005 Bone growth in length and width: The Yin and Yang of bone stability. J Musculoskelet Neuronal Interact 5:194-201.
3. Baron R 2003 General principles of bone biology. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, USA, pp 1-8.
4. Schenk R, Eggli P, Fleisch H, Rosini S 1986 Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38:342-349.
5. Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S 2003 Bisphosphonate-induced osteopetrosis. N Engl J Med 349:457-463.
6. Ward K, Cowell CT, Little DG 2005 Quantification of metaphyseal modeling in children treated with bisphosphonates. Bone 36:999-1002.
7. Grissom LE, Harcke HT 2003 Radiographic features of bisphosphonate therapy in pediatric patients. Pediatr Radiol 33:226-229.
8. Rauch F, Travers R, Munns C, Glorieux FH 2004 Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis. J Bone Miner Res 19:1191-1193.
9. Huiskes R, Ruimerman R, van Lenthe GH, Janssen JD 2000 Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 405:704-706.
10. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL 2002 Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60.
11. Salle BL, Braillon P, Glorieux FH, Brunet J, Cavero E, Meunier PJ 1992 Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants. Acta Paediatr 81:953-958.
12. Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM 2000 Normative data for iliac bone histomorphometry in growing children. Bone 26:103-109.
13. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
14. Rauch F, Travers R, Plotkin H, Glorieux FH 2002 The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293-1299.
15. Park EA 1964 The imprinting of nutritional disturbances on the growing bone. Pediatrics 33:815-862.
16. Rauch F, Travers R, Parfitt AM, Glorieux FH 2000 Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26:581-589.